Friday, October 23, 2026|20°C Partly Cloudy
Next edition scheduled
Your Personal Daily Intelligence
Edition 2026-08-17

CRYPTO

Oxbridge Re Provides 95% of Funding for SurancePlus Solana Tokenized Reinsurance Placements

Oxbridge Re Holdings provided about 95% of the $781,767 raised by SurancePlus in two Solana‑based tokenized reinsurance placements (T20 and T42) as shown in an August 13 filing.

By cryptoslate · 69d ago · Source: cryptoslate

Full article

Oxbridge Re Holdings provided about 95% of the $781,767 raised by SurancePlus in two Solana‑based tokenized reinsurance placements (T20 and T42) as shown in an August 13 filing. The two offerings were part of a $7.1 million aggregate that also included three securities linked to HCI Group’s reinsurance business, which generated $6.323 million in subscription proceeds. Oxbridge contributed roughly $744,623 while third‑party investors supplied $37,143. The filing does not disclose the identity of the HCI investors or separate third‑party demand for the full $7.1 million and notes that the transaction is consolidated within Oxbridge’s group. Tokenized reinsurance products are issued on blockchain platforms such as Solana and provide contractual rights without ownership or dividend entitlements. The T20 and T42 placements do not confer voting, dividend, or conversion rights; their payouts are contingent on the performance of the reinsurance contracts they reference. The $7.1 million figure reflects the combined subscription amounts for the T20, T42, and HCI‑linked offerings and aligns with Solana’s recent growth in real‑world asset tokenization, as indicated by a July 2026 report showing a doubling of RWA transfer volume over 30 days.

Source transparency

Publisher
cryptoslate
Reliability
high
Published
8/17/2026, 10:00:30 AM
Retrieved
8/17/2026, 10:00:30 AM
Relevance
80%
Confidence
85%
Read original at cryptoslate

Botwin's Morning Wire publishes the full source article for reading convenience. Please visit the publisher for the original presentation and any updates.